Havana.- Cuban researchers are developing several therapeutic vaccines against cancer, as part of a strategy to improve life quality.
The work is one of the priorities of Cuba’s Molecular Immunology Center, whose experts are carrying out a score of clinical trials in seven countries.
The research is being carried out in over 18 hospitals and 15 other health facilities are expected to be included in the program soon.
Phase-two tests on humans include vaccines against advanced lung, prostrate and colon cancers.
Hospitals in Cuba, Argentina and Spain are testing a drug against melanoma and breast cancer, while the radioactive R3 monoclonal antibody is being experimented on brain tumors.
Most resources from Cuban biotechnology are used in developing several vaccines, including some against such scourges as cholera and dengue fever.